Spiroksatrin

Spiroksatrin
	8-(2,3-dihidro-1,4-benzodioksin-2-ilmetil)-1-fenil-1,3,8-triazaspiro[4.5]dekan-4-on
Identifikacija
CAS registarski broj	1054-88-2
PubChem	5268
ChemSpider	5078
MeSH	Spiroxatrine
ChEMBL	CHEMBL300555
IUPHAR ligand	53
Jmol-3D slike	Slika 1
SMILES
	O=C2NCN(c1ccccc1)C23CCN(CC3)CC4Oc5ccccc5OC4
InChI
	InChI=1S/C22H25N3O3/c26-21-22(25(16-23-21)17-6-2-1-3-7-17)10-12-24(13-11-22)14-18-15-27-19-8-4-5-9-20(19)28-18/h1-9,18H,10-16H2,(H,23,26) ; Kod: JVGBTTIJPBFLTE-UHFFFAOYSA-N InChI=1/C22H25N3O3/c26-21-22(25(16-23-21)17-6-2-1-3-7-17)10-12-24(13-11-22)14-18-15-27-19-8-4-5-9-20(19)28-18/h1-9,18H,10-16H2,(H,23,26); Kod: JVGBTTIJPBFLTE-UHFFFAOYAW
Svojstva
Molekulska formula	C22H25N3O3
Molarna masa	379.45 g mol−1
	(šta je ovo?) (verifikuj) ; Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala
	Infobox references

Spiroksatrin je leki koji deluje kao selektivni antagonist za 5-HT_1A receptor i α_2C adrenergički receptor. On je analog spiperona. On takođe manifestuje neke od efekata dopaminskih antagonista.^[5]

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ J. E. Barrett, S. M. Hoffmann, S. N. Olmstead, M. J. Foust, C. Harrod and B. A. Weissman (1989). „Behavioral and neurochemical effects of the serotonin (5-HT)1A receptor ligand spiroxatrine”. Psychopharmacology 97: 319-325. DOI:10.1007/BF00439444. ^{[mrtav link]}

Portal Hemija